SPIC Frequency After Surgical Treatment of Peri-implantitis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Turin, Italy

About this trial

The leading hypothesis behind this study is that a 3-month frequency of supportive peri-implant care (SPIC) recalls after surgical therapy of implants affected by severe peri-implantitis yields better results when compared to a 6-month frequency. Thus, the primary aim of this randomized clinical trial is to compare 2 different frequencies of SPIC recalls (3 and 6 months) after surgical treatment of severe peri-implantitis in terms of treatment success (absence of implant loss, probing pocket depth (PPD) ≤ 5 mm at all aspects, bleeding on deep probing ≤1 site/implant, no suppuration at all aspects, bone loss \<0.5 mm) at early follow-up (1-year) and implant survival at the 5-year examination. Secondarily, this randomized clinical trial aims to assess the effects of the 2 different frequencies over clinical attachment levels around remaining teeth.

Eligibility criteria

Qualifiers

None

Disqualifiers

systemic diseases (e.g. uncontrolled diabetes mellitus) or chronic use of medications (e.g. corticosteroids, bisphosphonates) likely to influence the outcome of therapy or which contraindicates the study procedures;

smoking >10 cigarettes;

pregnant or nursing women.

history of peri-implantitis treatment on the eligible implants in the previous 6 months;

Trial design

Treatments tested in this trial

  • 3-month supportive peri-implant care (SPIC)
  • 6-month supportive peri-implant care (SPIC)

Treatment groups

152 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

University of Turin, Italy

Lead sponsor

Ege University

Collaborator